A Study of Xilonix for Improving Survival in Colorectal Cancer

Primary objectives: Overall survival (OS) will be the primary endpoint of this study, which will be measured from the date of randomization until death or last follow-up. Primary endpoints: Overall survival (OS)研究主要目标：本研究以总生存期（Overall Survival, OS）作为主要终点，该指标的评估周期为自随机分组日期起，至受试者死亡或末次随访之日止。 主要终点：总生存期（Overall Survival, OS）